Enhanced SOX10 and KIT expression in cutaneous melanoma

Medical Oncology

Volumn 30, Issue 3, 2013, Pages

  Rönnstrand, Lars ^a   Phung, Bengt ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KIT; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; SOX10 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR MARKER;

CUTANEOUS MELANOMA; GENE EXPRESSION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; DISEASE COURSE; GENETICS; MELANOMA; PATHOLOGY; SKIN TUMOR; UPREGULATION;

DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; MELANOMA; RECEPTOR PROTEIN-TYROSINE KINASES; SKIN NEOPLASMS; SOXE TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84879194961     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0648-y     Document Type: Letter

References (4)

1. Agnarsdottir M, Sooman L, Bolander A, Stromberg S, Rexhepaj E, Bergqvist M, et al. SOX10 expression in superficial spreading and nodular malignant melanomas. Melanoma Res. 2010;20(6):468-78. doi:10.1097/CMR.0b013e3283403ccd.
2. Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008;14(21):6821-8. doi:10.1158/1078-0432.ccr-08-0575.
3. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26): 4340-6. doi:10.1200/jco.2006.06.2984.
4. Nazarian RM, Prieto VG, Elder DE, Duncan LM. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study. J Cutan Pathol. 2010;37(Suppl 1):41-7. doi: 10.1111/j.1600-0560.2010.01505.x.